Share Search
Visit the Share Search
Cello Health sells Pulsar business to Access Intelligence
2nd Oct 2019 14:15
(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.
The AIM-listed company said on Wednesday that the disposal will allow it to focus its capital investment on the higher growth and higher margin healthcare business as well as supporting the development of the core Signal business.
The consideration will be satisfied through the issue of just over 8.6m ordinary shares of 5 pence each and a £1 cash payment. Following the acquisition, Cello will own around 11.3% of Access Intelligence.
Cello chief executive Mark Scott said: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."
The AIM-listed company said on Wednesday that the disposal will allow it to focus its capital investment on the higher growth and higher margin healthcare business as well as supporting the development of the core Signal business.
The consideration will be satisfied through the issue of just over 8.6m ordinary shares of 5 pence each and a £1 cash payment. Following the acquisition, Cello will own around 11.3% of Access Intelligence.
Cello chief executive Mark Scott said: "We are delighted that Pulsar can now begin the next stage in its development as a business whilst enabling Cello to focus on its core healthcare activities. We look forward to the ongoing partnership with Access Intelligence, both as a shareholder and as an ongoing user of Pulsar."